Cystic Fibrosis Weekly Update
Contents:
|
Early, Rapid BMI Increase May Affect Overall Growth of CF Children, Study Suggests
May 15, 2019 07:00 am | Alice Melão
Rapid weight gain early in life may have a long-term negative impact on the growth of children with cystic fibrosis (CF), a study has found. This finding suggests that nutritional interventions aimed at supporting the child’s normal growth should be implemented early on, taking into consideration their weight and overall body mass index. The study, […]
The post Early, Rapid BMI Increase May Affect Overall Growth of CF Children, Study Suggestsappeared first on Cystic Fibrosis News Today. |
|
In Cystic Fibrosis Awareness Month, I Look Back to Anticipate the Future
May 14, 2019 09:00 am | Brad Dell
The night I received my first Hill-Rom Vest — at age 5 — was a fun one. It was a beast of a machine in the mid-1990s, a white box weighing maybe 50 pounds. Large, plastic, hollow coils connected the machine to a bulky, black vest, which fitted around my torso and shoulders. The goal […]
The post In Cystic Fibrosis Awareness Month, I Look Back to Anticipate the Future appeared first on Cystic Fibrosis News Today. |
|
Phages, Viruses that Attack Bacteria, Are a Potential Therapy Against Infections, Case Report Suggests
May 14, 2019 07:30 am | Alejandra Viviescas
The case report of a cystic fibrosis (CF) patient suggests that phages — viruses that naturally infect and kill bacteria — are a potential personalized therapy against infections caused by antibiotic-resistant bacteria. The study, “Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus,” was published in the journal Nature Medicine. Patients […]
The post Phages, Viruses that Attack Bacteria, Are a Potential Therapy Against Infections, Case Report Suggests appeared first on Cystic Fibrosis News Today. |
|
Trial of Nebulized CF Candidate Therapy Completes Single-ascending Dosing
May 13, 2019 09:30 am | Patricia Inacio, PhD
The RESTORE-CF clinical trial investigating Translate Bio’s candidate therapy MRT5005 has completed the single-ascending dose regimen in patients with cystic fibrosis (CF), the company announced. The ongoing Phase 1/2 trial (NCT03375047) is testing the safety and efficacy of single and multiple escalating doses of nebulized MRT5005, compared with each other and a placebo, in 32 adults with CF who have class […]
The post Trial of Nebulized CF Candidate Therapy Completes Single-ascending Dosingappeared first on Cystic Fibrosis News Today. |
|
|
Recent News
|
|
|
No hay comentarios:
Publicar un comentario